ReviewPharmaceuticals (Basel, Switzerland)2025

Multitarget Compounds Designed for Alzheimer, Parkinson, and Huntington Neurodegeneration Diseases.

Eleftheria-Emmanouela Katsoulaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.